SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories’ arm receives approval to market RAN Donepezil in Canada

08 Jan 2014 Evaluate

Ranbaxy Laboratories' wholly owned subsidiary Ranbaxy Pharmaceuticals Canada Inc. (RPCI), has received an approval on December 24, 2013 to manufacture and market RAN-Donepezil Hydrochloride 5 mg and 10 mg tablets from Health Canada.

The total market size of Aricept (Donepezil Hydrochloride) in Canada is $153.9 million and growing at 38% (extended units). Donepezil Hydrochloride is indicated in the treatment of dementia in Alzheimer’s patients.

Ranbaxy Pharmaceuticals Canada Inc. (RPCI) based in Mississauga, Ontario, Canada, is a wholly owned subsidiary of Ranbaxy Laboratories, India’s largest pharmaceutical company. RPCI is engaged in the sale and distribution of generic prescription products in the Canadian healthcare system.

Peers
Company Name CMP
Sun Pharma Inds. 1800.00
Dr. Reddys Lab 1280.00
Cipla 1382.00
Zydus Lifesciences 1090.45
Lupin 2268.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: